Nasri Fatih

Nasri Fatih

Auto-generated profile, based on publicly available information

Nasri Fatih

Unit for Lifelong Health and Ageing at UCL, London, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Neurobiology of Aging
Verified
Journal Article
Open access
NFNasrtullah Fatih
Nasrtullah Fatih
NCNishi Chaturvedi
Nishi Chaturvedi
CLChristopher Lane
Christopher Lane
TPThomas D. Parker
Thomas D. Parker
KLKirsty Lu
Kirsty Lu
SJSarah-Naomi James
Sarah-Naomi James
Longitudinal studies of the relationship between hyperglycemia and brain health are rare and there is limited information on sex differences in associations. We investigated whether glycosylated hemoglobin (HbA1c) measured at ages of 53, 60-64 and 69 years, and cumulative glycemic index (CGI), a measure of cumulative glycemic burden, were associated with metrics of brain health in later life. Participants were from Insight 46, a substudy of the Medical Research Council National Survey of Health and Development (NSHD) who undertook volumetric MRI, florbetapir amyloid-PET imaging and cognitive assessments at ages of 69-71. Analyses were performed using linear and logistic regression as appropriate, with adjustment for potential confounders. We observed a sex interaction between HbA1c and whole brain volume (WBV) at all 3 time points. Following stratification of our sample, we observed that HbA1c at all ages, and CGI were positively associated with lower WBV exclusively in females. HbA1c (or CGI) was not associated with amyloid status, white matter hyperintensities (WMHs), hippocampal volumes (HV) or cognitive outcomes in either sex. Higher HbA1c in adulthood is associated with smaller WBV at 69-71 years in females but not in males. This suggests that there may be preferential target organ damage in the brain for females with hyperglycemia.

5 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
NFNasri Fatih
Nasri Fatih
NCNishi Chaturvedi
Nishi Chaturvedi
VGVictoria Garfield
Victoria Garfield
CSCarole H. Sudre
Carole H. Sudre
RSRichard J Silverwood
Richard J Silverwood
SJSarah-Naomi James
Sarah-Naomi James
Previous studies have found that diabetes and its mechanistic factors (e.g. glycaemia) are associated with poorer cognitive and brain health. There is also growing evidence of sex differences in how diabetes manifests itself and impacts the brain. The mechanisms through which this association manifests itself are still poorly understood, but the possible role of inflammation has been proposed. This study aims to explore whether the relationship between mid-life glycaemia and brain volumes in later-life in women is mediated by systemic inflammation. The sample consisted of female participants from the National Survey of Health and Development (NSHD) who underwent neuroimaging as part of the Insight 46 sub-study. Path analysis models were then constructed between glycaemic markers (age 60-64) and brain health outcomes (age 69-71) with adjustments for social and metabolic confounders (age 60-64). Although glycaemia was mostly associated with a higher systemic inflammatory state in two of the three markers (e.g., HbA1c and interleukin-6: β = 0.05 [0.02. 0.01], p = 0.001 and glycoprotein A: β = 0.02 [=-0.01. 0.02], p = 0.001), we did not find a relationship between inflammation and our brain volume markers [whole brain, grey matter and white matter] (e.g. interleukin-6 and whole brain volume: β = -3.1 [=-7.7. 1.5], p = 0.2; interleukin-6 and grey matter: β = -0.3 [=-1.8. 1.2], p = 0.7), thus no mediated effect between the glycaemic markers and outcomes via the pathway of systematic inflammation. This raises the possibility alternative mechanistic pathway, to inflammation, playing a role in the relationship between hyperglycaemia and brain health outcomes.

10 March 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NFNasri Fatih
Nasri Fatih
NCNish Chaturvedi
Nish Chaturvedi
VGVictoria Garfield
Victoria Garfield
CSCarole H. Sudre
Carole H. Sudre
RSRichard J. Silverwood
Richard J. Silverwood
SJSarah-Naomi James
Sarah-Naomi James
Previous studies have found that diabetes and its mechanistic factors (e.g., glycaemia) are associated with poorer cognitive and brain health. There is also growing evidence of sex differences in how diabetes manifests itself and impacts the brain. The mechanisms through which this association manifests itself are still poorly understood, but the possible role of inflammation has been proposed. This study aims to explore whether the relationship between mid-life glycaemia and brain volumes in later-life in women is mediated by systemic inflammation. The sample consisted of female participants from the National Survey of Health and Development (NSHD) who underwent neuroimaging as part of the Insight 46 sub-study. Path analysis models were then constructed between glycaemic markers (age 60−64) and brain health outcomes (age 69−71) with adjustments for social and metabolic confounders (age 60−64). Although fasting glucose was associated with higher GlycA levels (β = 0.05 [0.01, 0.10], p = 0.005), associations with CRP and IL-6 were weaker and not statistically significant (e.g., IL-6: β = 0.10 [−0.04, 0.30], p = 0.102). However, we did not find evidence that inflammatory markers were associated with brain volume outcomes (e.g., IL-6 and whole brain volume: β = −3.4 [−8.1, 1.3], p = 0.092; IL-6 and grey matter volume: β = −0.4 [−1.9, 1.0], p = 0.512). Consequently, indirect (mediated) effects via systemic inflammation were not observed. This suggests that alternative mechanisms beyond inflammation may contribute to the relationship between mid-life glycaemia and later-life brain health.

12 February 2026 in BMJ Open
Verified
Journal Article
Open access
NFNasri Fatih
Nasri Fatih
KBKrishnan Bhaskaran
Krishnan Bhaskaran
AKAden Chun Hei Kwok
Aden Chun Hei Kwok
KEKlaus P Ebmeier
Klaus P Ebmeier
TNThomas Nichols
Thomas Nichols
ATAnya Topiwala
Anya Topiwala
Introduction: Alcohol consumption is an increasingly recognised modifiable risk factor for dementia, yet whether it has differential impacts on dementia subtypes and its role in disease progression remains unclear. This study aims to: (1) quantify the association between alcohol intake and incidence of dementia subtypes and (2) examine whether individuals who drink heavily and develop dementia referred to hereafter as ‘alcohol-related’—have poorer post-diagnosis outcomes compared with other dementia cases. Clarifying these relationships will determine whether alcohol selectively increases risk for specific dementia phenotypes or broadly heightens neurodegenerative vulnerability, with implications for prevention, clinical counselling and therapeutic targeting. Methods and analysis: This population-based cohort study of alcohol and dementia will use linked UK electronic health records from Clinical Practice Research Datalink, Hospital Episode Statistics and Office for National Statistics (ONS). Participants will be eligible if they have available linked data from January 1998, when ONS death registrations became available, until the end of follow-up. Alcohol exposure will be defined through self-reported recorded weekly alcohol units and diagnostic codes for harmful or dependent alcohol use. Primary outcomes including incident all-cause and subtype-specific dementia (eg, Alzheimer’s, vascular, Lewy body, Parkinson’s, frontotemporal) as well as secondary outcomes (ie, mortality, care-home entry and neuropsychiatric symptoms). Key covariates encompassing socio-demographic factors, smoking and relevant comorbidities will be adjusted for. Multivariable Cox proportional hazards and Fine-Gray competing risk models will estimate associations with dementia incidence. Post-diagnosis prognosis will be compared for dementia in individuals with a history of heavy alcohol use (‘alcohol-related’) and dementia in individuals with minimal alcohol exposure (‘non-alcohol-related’) cases using survival and logistic regression models. Multiple testing correction will be applied across dementia subtype comparisons. Alcohol exposure will be modelled continuously and non-linearly using restricted cubic splines and categorically using binary indicators of harmful/dependent use. Missing covariate data will be assessed and addressed using appropriate methods, including multiple imputation and complete-case analysis. Data extraction and analysis are scheduled from October 2025 to October 2026. Ethics and dissemination: Use of de-identified routine data will proceed under existing Research Ethics Committee and data governance approvals. Findings will be disseminated via open-access peer-reviewed journals, academic conferences and summaries targeted at patient, public and policy audiences. The results of this study will be reported according to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) and The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) guidelines.

13 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
NFNasri Fatih
Nasri Fatih
SJSarah-Naomi James
Sarah-Naomi James
NCNishi Chaturvedi
Nishi Chaturvedi
AHAlun D. Hughes
Alun D. Hughes
VGVictoria Garfield
Victoria Garfield
Aims: Diabetes and hyperglycaemia are associated with poorer brain health, but most studies focus on diagnosed diabetes and rarely examine non-linear or sex-specific associations between glycaemia and neuroimaging biomarkers. We investigated whether glycaemia shows non-linear associations with brain structure and whether these differ by sex. Methods: In 36,321 UK Biobank participants, sex-stratified fractional polynomial models assessed associations of random glucose and HbA1c with brain MRI volumes, adjusted for covariates. Restricted cubic splines and range-restricted linear models assessed robustness and estimated sex-specific slopes. Results: Associations of glycaemia with whole brain and grey matter volumes were inverted J-shaped in both sexes, with lower volumes at higher glycaemia and less consistent evidence of lower volumes at the lower end. Predicted whole brain volume peaked at glucose values between 4.4 and 4.7 mmol/L and HbA1c values between 33 and 37 mmol/mol. Restricted cubic splines confirmed non-linearity for glucose with whole brain volume (p_non-linearity=0.006) and grey matter (p_non-linearity<0.001), with evidence of sex interaction (p_interaction=0.02–0.03). For HbA1c, splines supported non-linearity for whole brain volume (p_non-linearity=0.006) and grey and white matter volumes (both p_non-linearity<0.001), with little evidence of sex interaction (p_interaction≥0.4). White matter hyperintensity volume showed a J-shaped association for HbA1c (p_non-linearity=0.002), with no evidence of sex interaction. Linear models in the descending range indicated steeper glucose-associated declines in whole brain and grey matter volumes in females than males. Conclusions: Glycaemia–brain imaging associations were non-linear. Higher glycaemia was associated with less favourable brain structural profiles, with stronger associations for glucose in females. These findings indicate that associations between glycaemia and brain structure extend across the glycaemic spectrum rather than being limited to clinically defined diabetic states. What is already known about this subject?: Diabetes is associated with adverse brain outcomes including reduced brain volume and greater small vessel disease burden and is an established risk factor for dementia. Most neuroimaging studies have focused on diabetes status rather than the full glycaemic continuum and have relied on sex-pooled analyses. Emerging evidence suggests glycaemia may relate to health outcomes nonlinearly and that these relationships may differ by sex. What is the key question?: Is glycaemia associated with structural brain health across its full range, including below diabetes diagnostic thresholds, and do these associations show nonlinear or sex-specific patterns? What are the new findings?: We found evidence of nonlinear associations between glycaemia and brain structure in both sexes, with inverted J-shaped associations for whole brain and grey matter volumes. Higher glycaemia was associated with less favourable brain structural profiles across the glycaemic continuum, including within the non-diabetic range. Sex differences were observed particularly for glucose, with steeper declines in brain volumes at higher glycaemic levels in females than males. How might this impact on clinical practice in the foreseeable future?: These findings reinforce the importance of considering glycaemia as a continuous exposure rather than relying on diagnostic thresholds when evaluating metabolic contributions to brain ageing.

29 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
NFNasri G Fatih
Nasri G Fatih
DHDavid Hippisley-Cox
David Hippisley-Cox
KEKlaus P Ebmeier
Klaus P Ebmeier
JGJoel Gelernter
Joel Gelernter
GRGillian K. Reeves
Gillian K. Reeves
ATAnya Topiwala
Anya Topiwala
Background: Alcohol use disorder (AUD) is associated with increased dementia risk, but its long-term relationship with dementia, variation by age and subtype, and how this risk compares with that associated with alcohol consumption remain poorly characterised. We investigated these questions in a large prospective cohort of UK women. Methods: We analysed Million Women Study participants recruited aged 50–64 years and followed for more than 20 years through linked health records. Women with hospital-recorded AUD were matched to up to five controls. Cox models estimated associations between time-varying AUD and incident dementia overall, by subtype, attained age, with exposure lags of up to 15 years and competing-risk analyses. Self-reported alcohol consumption was analysed separately. Findings: Among 1,288,359 women, 20,070 with AUD were matched to 100,339 controls. Dementia occurred in 3,774 women with AUD and 8,239 matched controls. AUD was associated with all-cause dementia (HR=3·73[95% CI 3·52–3·95]), with strongest associations for mixed (5·03[3·88–6·51]), unspecified (4·29[3·92–4·70]), and vascular dementia (3·96[3·44–4·56]). Associations were substantially stronger before age 70 years (10·68[9·02–12·63]) than at ages 70-79 (3·75[3·47–4·04]) or ≥80 years (2·34[2·11–2·60]). Risk remained elevated with a 15-year lag (2·16[1·81–2·58]) and after accounting for competing mortality. Associations with self-reported alcohol consumption were substantially weaker. Interpretation: Clinically recognised AUD identifies women at markedly increased and prolonged dementia risk, particularly at younger ages and for vascular and mixed dementia, not captured by drinking quantity alone. People with AUD should be considered a priority population for earlier dementia prevention and risk reduction. Funding: Wellcome Trust Career Development Award to AT (306069/Z/23/Z); NIH grants P50AA012870 and R01DA054869 (JG). The Million Women Study is supported by the UK Medical Research Council (grant number UKRI1464)